Orthofix Wins "Best Patient Experience Solution" Award in 2024 MedTech Breakthrough Awards Program
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has been selected as winner of the "Best Patient Experience Solution" award in the 8th annual MedTech
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
Orthofix Gets FDA Clearance for Rodeo Telescopic Nail
Express News | Orthofix Announces FDA 510(K) Clearance for the Rodeo Telescopic Nail
Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call Transcript
Roth MKM Ups Orthofix to Buy, Cites Improving Fundamentals
Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Piper Sandl
Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target
Orthofix Medical (OFIX) has an average outperform rating and a price target range of $14 to $26.40, according to analysts polled by Capital IQ.
Orthofix Medical Raised to Buy From Neutral by Roth MKM
Orthofix Medical Raised to Buy From Neutral by Roth MKM
Express News | Roth MKM Upgrades Orthofix Medical to Buy, Raises Price Target to $20
Orthofix Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 43.99% Roth MKM $15 → $20 Upgrades Neutral → Buy 04/22/2024 — JMP Securities Reiterates → Mark
Orthofix Medical Inc (OFIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
Q1 2024 Orthofix Medical Inc Earnings Call
Orthofix Medical Inc. (OFIX) Q1 2024 Earnings Call Transcript
Orthofix Medical Inc. (OFIX) Q1 2024 Earnings Call Transcript
Orthofix Medical Inc. Q1 Loss Decreases, but Misses Estimates
Express News | Orthofix Cuts FY24 Revenue Outlook From $785M - $795M To $790M - $795M Vs. $790.82M Est
Orthofix Medical | 10-Q: Quarterly report
Express News | Orthofix Medical Inc - Qtrly Shr Loss $0.95
Orthofix Medical Q1 EPS $(0.95) Misses $(0.33) Estimate, Sales $188.60M Beat $184.13M Estimate
Orthofix Medical (NASDAQ:OFIX) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.33) by 187.88 percent. This is a 850 percent decrease over losses of $(
Orthofix Medical 1Q Sales $188.6M >OFIX
Orthofix Medical 1Q Sales $188.6M >OFIX
No Data